THYROID HORMONES play important roles in development, differentiation, and metabolism through binding of 3,5,3Ј-triiodothyronine (T 3 ) to nuclear receptors that regulate the expression of genes coding for specific proteins (65) . A major target of these long-term effects is the Na ϩ -K ϩ -ATPase (40) as shown both in vivo (38, 39) and by in vitro studies carried out on primary culture rat hepatocytes and rat liver cell lines (27, 33) .
Short-term effects of thyroid hormones also have been described, indicating the existence of mechanisms independent of nuclear receptors and protein synthesis, but instead involving the plasma membrane, mitochondria, or the cytoskeleton (18, 19) . In rat thymocytes in vitro T 3 caused, within few minutes, an increase in cytoplasmic Ca 2ϩ concentration together with an increase in adenylate cyclase activity, cAMP content, and 2-deoxyglucose uptake (58 -60) . Thyroxine (T 4 ), T 3 , and, to a lesser extent, the analog 3,5-diiodothyronine (3,5-T 2 ), stimulated red blood cell and skeletal muscle Ca 2ϩ -ATPase activity (17, 64) , whereas only T 3 activated the Na ϩ /H ϩ antiport in L6 myoblasts (36) . Stimulation of the Na ϩ /H ϩ antiport together with the Na ϩ -dependent amino acid transport was shown to be mediated by protein kinase C (PKC), phosphoinositide 3-kinase (PI3-K), and the MAP kinase pathway in chick embryo hepatocytes (23, 35, 37) . Together, these results provide evidence for the involvement of plasma membrane receptors and plasma membrane-associated signal transduction pathways in the short-term nongenomic effects of thyroid hormones. Actually, the presence of highaffinity binding sites for T 3 has been reported for erythrocyte membranes (3, 8) , neuroblastoma plasma membranes (32) , chick embryo brain synaptosomes (28, 29) , and rat liver plasma membranes (54) . It was recently shown that in CV-1 cells, rapid effects elicited by T 4 were initiated at the plasma membrane level through the interaction with an ␣ V ␤ 3 integrin (5). The short-term effects of thyroid hormones were in many cases found to involve signal transduction pathways and second messenger systems that lead to activation of protein kinases (5, 20, 28, 35, 36, 41, 46, 47, 62) . Reversible phosphorylation of specific proteins by the activated kinases may therefore represent a fundamental step in the pathway that allows short-term modulation of cell response to thyroid hormones. Na ϩ -K ϩ -ATPase, the sodium pump responsible for the unequal distribution of Na ϩ and K ϩ across the cell membrane and for its maintenance, is a membrane enzyme consisting of two subunits, ␣, the catalytic component of the enzyme, and ␤, which are expressed in multiple isozymic forms. Much evidence indicates that phosphorylation of the catalytic ␣-subunit of Na ϩ -K ϩ -ATPase by protein kinases is one of the mechanisms involved in the short-term modulation of pump activity by different agents (22, 63) .
Several studies have documented short-term effects of thyroid hormones on Na ϩ -K ϩ -ATPase: T 3 enhanced Na ϩ -K ϩ -ATPase activity in the liver of a teleost fish (61) , and in rat alveolar epithelial cells T 3 stimulated Na ϩ -K ϩ -ATPase activity through a mechanism that involved the PI3-K, Src kinase, and MAPK-ERK1/2 activation (42) (43) (44) . The same authors reported that T 3 , via a PI3-K-dependent pathway, could stimulate in an age-related manner the activity of Na ϩ -K ϩ -ATPase also in a primary culture of rat fetal lung epithelial cells (45) . In contrast, we have recently documented that both T 3 and 3,5-T 2 , a metabolic product of thyroid hormone able to mimic many extranuclear effects of T 3 (2, 30, 31, 35, 37, 48, 51) , inhibited in a time-and dose-dependent manner the activity of Na ϩ -K ϩ -ATPase of chick embryo hepatocytes isolated at different developmental stages (37) .
In the present study we have investigated the signal transduction pathways involved in the nongenomic effects of thyroid hormones and 3,5-T 2 on the Na ϩ -K ϩ -ATPase activity of chick embryo hepatocytes, isolated at 14 and 19 days of embryonal age. At these stages of their development, characterized by intense proliferative activity and differentiation, the hepatocytes show critical physiological changes that appear well correlated with both the circulating levels of iodothyronines and with their hepatic metabolism (2) . For these cells it has been shown that thyroid hormones T 4 , T 3 , and 3,5-T 2 are able to regulate DNA synthesis, cell-cycle proteins (2) , and some membrane-associated transport systems whose activity is related to cell proliferation (35, 37) . Our results indicate that thyroid hormone T 3 (and 3,5-T 2 ), via a short-term mechanism, exerts on the Na ϩ -K ϩ -ATPase an inhibitory effect whose magnitude appears strongly correlated to the developmental age of the isolated cells.
The Na ϩ -K ϩ -ATPase inhibition by T 3 and 3,5-T 2 appears to be mediated through the activation of PKA, PKC, and PI3-K, suggesting 1) a role for phosphorylation and possibly endocytosis in the modulation of the Na ϩ -K ϩ -ATPase activity and 2) that signal transduction pathways contributing to the modulation of the sodium pump by thyroid hormones are also involved in the control that the same hormones exert on cell proliferation. (3,5-T2) , PKA inhibitor peptide IP20, forskolin, wortmannin, dibutyrylcAMP, phorbol 12-myristate 13-acetate (PMA), 1-oleoyl-2-acetyl-snglycerol (OAG), and RO 31-8220 were supplied by Sigma (St. Louis, MO). Calphostin C and PD 98059 were obtained from Alexis Biochemicals (Laufelfingen, Switzerland). All other chemicals were supplied by Merck (Darmstadt, Germany).
MATERIALS AND METHODS

Materials. Collagenase (type D) was obtained from Roche Molecular
Hepatocytes preparation and culture. Chick embryo hepatocytes were isolated using an already described procedure (15) . Briefly, pooled livers from White Leghorn (Gallus gallus) chick embryos (14 and 19 days of embryonal age) were rapidly removed, cut to small pieces, washed in ice-cold Hanks' buffer, and incubated three times for 10 min at 37°C with 0.3 mg/ml collagenase in Hanks' buffer (7 ml/g liver). During incubations, the buffer was continuously gassed with an atmosphere of 5% CO 2. At the end of each incubation, the media were aspirated, pooled together, and centrifuged for 5 min at 80 g at 4°C. Isolated hepatocytes (4.0 ϫ 10 6 cells/60-mm collagencoated dish) were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 200 mM L-glutamine, 5% (vol/vol) fetal calf serum, 2.5 ng/ml amphotericin, 0.1 mg/ml gentamicin, and 0.25 M dexamethasone in a humidified atmosphere of 5% CO 2 at 37°C and used after 48 h.
Determination of Na ϩ -K ϩ -ATPase activity. Cell monolayers (4 ϫ 10 6 cells/dish), at 48 h from plating, were incubated in the same culture medium supplemented with T4, T3, or 3,5-T2 (100 nM) in a shaker water bath at 37°C for different times. Incubations were terminated by rapidly cooling the dishes on ice, the medium was discarded, and the monolayers were rinsed three times with an ice-cold buffer consisting of 250 mM sucrose, 10 mM tris(hydroxymethyl)aminomethane (Tris), and 1 mM EDTA, pH 7.4. Hepatocytes were harvested in a small volume (0.8 ml) of the same buffer, and the suspension was homogenized with a Dounce homogenizer (20 -30 strokes). The homogenate was then centrifuged at low speed (3,000 rpm for 10 min at 4°C) to remove cell debris and nuclei, and the resulting supernatant was used in enzyme assays. Cell monolayers were incubated and processed in the same way, but in the absence of the hormones, they were used as controls. For Na ϩ -K ϩ -ATPase activity assays, 100 l of the low-speed supernatant (40 -50 g of cell proteins) were added to 800 l of reaction mixture and preincubated for 10 min at 37°C; the reaction was started by the addition of 100 l of ATP. The reaction mixture consisted of (final concentrations in 1 ml) 130 mM NaCl, 20 mM KCl, 4 mM MgCl 2, 0.2 mM EGTA, 90 mM Tris ⅐ HCl, and 5 mM Na 2ATP, pH 7.4, for total ATPase determination. Ouabain-insensitive ATPase activity was determined in a mixture devoid of KCl and containing (1 ml final volume) 150 mM NaCl, 4 mM MgCl 2, 0.2 mM EGTA, 90 mM Tris ⅐ HCl, 5 mM Na 2ATP, and 1 mM ouabain, pH 7.4. After 10 min of incubation at 37°C, the reaction was stopped by adding 2 ml of cold 10% (wt/vol) trichloroacetic acid (TCA) and enzyme activity was estimated by determining the phosphate released from ATP hydrolysis. Inorganic phosphate (P i) was quantitated with a colorimetric method by adding 3 ml of 1% (wt/vol) ammoniumheptamolybdate in 0.6 M H 2SO4 supplemented before use with 4 g of FeSO4 ⅐ 7H2O, and absorbance was read at 700 nm. Na ϩ -K ϩ -ATPase activity was calculated as the difference between total ATPase and ouabain-insensitive ATPase activity and was expressed as either micromoles of P i per milligram of protein per hour or the percentage of basal activity. Protein content in the low-speed supernatant of chick embryo hepatocytes was determined using the method of Lowry et al. (49) with bovine serum albumin as a standard.
Studies with protein kinase modulators. When the effects of protein kinase activators or inhibitors on Na ϩ -K ϩ -ATPase were to be studied, hepatocyte monolayers (4 ϫ 10 6 cells/dish) were pretreated 10 min at 37°C with one of the following: 10 M forskolin, 0.1 nM IP20, 10 M RO 31-8220 (1), 1.0 M calphostin C (9), 100 nM wortmannin (55), or 10 M PD 98059, an inhibitor of the ERK1/2 at the distal part of the MAPK pathway (21) , and then incubated for an additional 5 min at 37°C either alone or in combination with 100 nM T3 or 3,5-T2. The effects of 1 mM dibutyryl-cAMP, 20 M PMA, and 100 M OAG were also examined for comparison. All samples were then processed for Na ϩ -K ϩ -ATPase activity determination. Cell monolayers receiving either solvent or solvent plus hormones were always run in parallel as controls.
Assays of cAMP, inositol-1,4,5-trisphosphate, and diacylglycerol production. For cAMP and inositol-1,4,5-trisphosphate (IP3) determinations, control and thyroid hormone-treated (T3 and 3,5-T2, 100 nM final concentration) hepatocyte monolayers (4 ϫ 10 6 cells/dish) were incubated in a shaker water bath at 37°C for 5 min, as previously reported (37) . Incubation was terminated by rapidly cooling the dishes on ice and adding 400 l of an ice-cold 10% (wt/vol) TCA-2 mM EDTA solution. Hepatocytes were kept on ice for 15 min, scraped, and centrifuged 15 min at 3,000 g at 4°C. The supernatant was washed free of TCA by three washings with 8 volumes of water-saturated diethyl ether. cAMP and IP3 contents were determined with the assay kits TRK 432 and TRK 1000 (Amersham Pharmacia Biotechnology), respectively, and expressed as picomoles per 10 6 cells. The pellet was dissolved in 1 ml of 1 M NaOH at 100°C and used for protein determination. For diacylglycerol (DAG) determination, 24-h cultured hepatocytes (4 ϫ 10 6 cells/dish) were incubated for 20 h in the presence of 1 Ci/dish [ 14 C]myristic acid (Amersham Pharmacia Biotechnology; specific activity 40 -60 Ci/mmol). At the end of this incubation, cell cultures were rinsed in phosphate-buffered saline (PBS) to eliminate excess radioactivity and incubated with 2 ml of a Krebs-Henseleit buffer containing bovine serum albumin (fatty acid free) in the absence (controls) or presence of thyroid hormones (100 nM final concentration). After 5 min at 37°C, dishes were cooled on ice and washed in 20 mM Tris ⅐ HCl buffer, pH 7.4, containing 0.15 M NaCl. DAG was extracted using a solvent mixture consisting of chloroform-methanol-water (2:2:1 by volume). The chloroform phase was concentrated under a stream of nitrogen, and aliquots were used for DAG estimation. Separation of DAG was carried out by thin-layer chromatography on silica gel G plates using benzene-methanol-chlo-roform (80:15:5 by volume) as developing solvent. The silica gel area corresponding to DAG fraction was scraped off the plate, and incorporated radioactivity was determined with a liquid scintillation counter. DAG production was expressed as disintegrations per minute per milligram of protein.
Preparation of T 3-agarose. T3-agarose was prepared as previously reported (16) . Activated CH Sepharose 4B (Sigma) was washed in HCl at low speed to discard contaminants and impurities. T 3 was then added and mixed gently with Sepharose in a 2:1 ratio at room temperature for 2 h. After the reaction, the suspension was washed three times at 500 g for 5 min with a solution of 0.1 M Tris ⅐ HCl and 0.5 M NaCl, pH 8, and three times at 500 g for 5 min with a solution of 0.1 M sodium acetate and 0.5 M NaCl, pH 4. T 3-agarose prepared following this protocol has a final concentration of ϳ10 mol/ml and can be stored at 4 -8°C for a couple of months. The contamination by free T 3 was below 0.070 pmol/ml as assessed by radioimmunoassay (16) .
Statistics. Values are means Ϯ SE. P values were calculated using Student's t-test, and P Ͻ 0.05 was taken as significant. When several groups were to be compared, statistical significance was determined using one-way ANOVA and the Newman-Keuls test for multiple comparison, using GraphPad software Prism 4.
RESULTS
Effect of thyroid hormones on the Na
ϩ -K ϩ -ATPase activity. The time dependence of the effects of thyroid hormones T 4 and T 3 and of 3,5-T 2 on Na ϩ -K ϩ -ATPase activity of 14-and 19-day-old chick embryo hepatocytes are reported in Fig. 1 . In control hepatocytes, Na ϩ -K ϩ -ATPase specific activity was significantly higher in 19-than in 14-day-old embryos; basal values recorded after 5 min of incubation at 37°C were 2.495 Ϯ 0.093 and 1.321 Ϯ 0.047 mol P i ⅐mg protein Ϫ1 ⅐h
Ϫ1
(mean Ϯ SE) for 19-and 14-day-old embryos, respectively, and remained stable within 15 min of incubation. We have previously reported a full dose-response study for the effect of thyroid hormones on the Na ϩ -K ϩ -ATPase activity, showing a highly significant inhibition in 5 min at 100 nM for both T 3 and 3,5-T 2 (37) . This range of concentrations has been used by several authors to study nongenomic effects of thyroid hormones (36 -38, 46, 47) . In the present study, T 3 inhibited Na ϩ -K ϩ -ATPase to 1.081 Ϯ 0.089 (81.6 Ϯ 4.1%) and 1.454 Ϯ 0.109 (58.5 Ϯ 6.8%) mol P i ⅐mg protein Ϫ1 ⅐h Ϫ1 of basal activity in 14-and 19-day-old embryos, respectively (Fig. 1) . In both experimental groups, the inhibitory effect was very rapid and completely reversed within 15 min to control values. Compared with T 3 , 3,5-T 2 was a more efficient inhibitor of the Na ϩ -K ϩ -ATPase; an inhibition to 0.765 Ϯ 0.064 mol P i ⅐mg protein Ϫ1 ⅐h Ϫ1 (57.9 Ϯ 3.6%) was observed at 14 days with respect to 0.893 Ϯ 0.13 mol P i ⅐mg protein Ϫ1 ⅐h Ϫ1 (35.4 Ϯ 3.7%) of basal activity recorded at 19 days of embryonal age, with the difference between the two hormones being highly significant ( Fig. 1 ). At variance with T 3 , inhibition by 3,5-T 2 was completely abolished after 15 min from hormone treatment only in the 19-day-old hepatocytes, whereas enzyme activity was still inhibited in the younger cells. Cell treatment with 100 nM T 4 had no detectable effects on the Na ϩ -K ϩ -ATPase activity of either age group throughout the 15-min experimental period (Fig. 1) . T 3 -agarose (100 nM) fully mimicked the inhibition of the Na ϩ -K ϩ -ATPase activity by thyroid hormone at both developmental stages ( Table 1 ), confirming that the hormone effect is at the plasma membrane level (37) .
Effect of T 3 and 3,5-T 2 on Na ϩ -K ϩ -ATPase activity: role of PKA and PKC. Several hormonal agents can regulate Na ϩ -K ϩ -ATPase activity by reversible phosphorylation of the catalytic ␣-subunit of the enzyme via mechanisms that involve signal transduction pathways leading to PKA and/or PKC activation (22, 63) . To determine the possible involvement of these kinases in the inhibition of chick embryo Na ϩ -K ϩ -ATPase by thyroid hormones, we carried out experiments in which 14-and 19-day-old hepatocytes were exposed, in the absence or presence of T 3 or 3,5-T 2 , to agents that directly or indirectly modulate PKA and PKC activity. The effects of thyroid hormones were compared with those elicited by forskolin, which, by activating adenylate cyclase, increases intracellular levels of cAMP and PKA activity. With respect to basal activity, incubation of 19-day-old hepatocytes with 10 M forskolin for 5 min inhibited Na ϩ -K ϩ -ATPase activity to 41.7 Ϯ 4.1%, a level comparable to that elicited by 5-min treatment with 100 nM T 3 (63.7 Ϯ 4.2%) or 3,5-T 2 (40.4 Ϯ 3.0%) (Fig. 2) . A similar inhibitory effect was observed when the hepatocytes were coincubated with forskolin and either T 3 or 3,5-T 2 or exposed to 1 mM dibutyryl-cAMP to activate PKA directly (Fig. 2) . Thus the inhibitory effects of thyroid hormones and PKA activation are clearly not additive, suggesting that PKA activation represents a step in the mechanism that leads to Na ϩ -K ϩ -ATPase inhibition by thyroid hormones. This is supported by experiments in which hepatocytes were treated with IP 20 , a 20-residue peptide known to inhibit PKA activity. The peptide IP 20 completely abolished the effects of T 3 and 3,5-T 2 , whereas it had no effect on the Na ϩ -K ϩ -ATPase activity when present alone (Fig. 2, C and D) . Similar patterns of response were found in 14-day-old hepatocytes. The inhibitory effects of T 3 and 3,5-T 2 were mimicked by forskolin when given together with iodothyronines and by dibutyrylcAMP and were abolished by the PKA inhibitor IP 20 (Fig. 2, A  and B) . From these results, it appears that signal transduction pathways leading to PKA activation are already operative at this early embryonal stage. It has been reported that direct activation of PKC by phorbol esters or by DAG inhibits Na ϩ -K ϩ -ATPase activity in different cell systems (6, 50) . To determine whether Na ϩ -K ϩ -ATPase also is affected by the same agents in chick embryo hepatocytes, cells were incubated with PMA (20 M) or OAG (100 M). As shown in Fig. 3 , C and D, exposure of 19-dayold hepatocytes to phorbol ester or OAG caused a significant decrease in Na ϩ -K ϩ -ATPase activity, comparable to that observed when the cells were treated with T 3 or 3,5-T 2 (100 nM). To confirm the involvement of PKC, we tested the effects of two selective PKC inhibitors, RO 31-8220 and calphostin C. Coincubation of the hepatocytes with RO 31-8220 (10 M) or calphostin C (1 M) and T 3 or 3,5-T 2 abolished the effects of thyroid hormones on Na ϩ -K ϩ -ATPase activity (Fig. 3, C and  D) . At variance with the results obtained on 19-day-old cells, incubation of 14-day-old hepatocytes with PKC inhibitors RO 31-8220 and calphostin C not only failed to block the effects of thyroid hormones but also exerted a strong inhibition when present alone (Fig. 3, A and B) . Significant inhibition of Na ϩ -K ϩ -ATPase activity also was observed when 14-day-old hepatocytes were treated with PMA (20 M) or OAG (100 M) (Fig. 3, A and B) .
Because the data reported so far pointed to the involvement of PKA and PKC in thyroid hormone-dependent inhibition of Na ϩ -K ϩ -ATPase, we carried out experiments to verify whether T 3 or 3,5-T 2 treatment of chick embryo hepatocytes had any effect on intracellular levels of cAMP and DAG, the second messengers in the signal transduction pathways leading to PKA and PKC activation. Incubation of 14-and 19-day-old hepatocytes with T 3 or 3,5-T 2 for 5 min resulted in a significant increase in the levels of cAMP (Fig. 4C) , providing indirect evidence that PKA activation is involved in the inhibitory effects of Na ϩ -K ϩ -ATPase by thyroid hormones. The initial event in the signal transduction pathway that leads to PKC activation is the hydrolysis of phosphatidylinositol 4,5-bisphosphate by a specific phospholipase C (PLC), from which two second messenger systems originate: DAG, which promotes the rapid activation of PKC, and IP 3 , which mobilizes Ca 2ϩ from intracellular stores. An increase in DAG production would confirm that PKC activation is one of the possible mechanisms for the inhibition of Na ϩ -K ϩ -ATPase by thyroid hormones. To verify this hypothesis, we determined the levels of DAG, together with IP 3 production, after 5 min of incubation with T 3 or 3,5-T 2 . DAG was significantly increased after hormone treatment in both experimental groups (Fig. 4, A  and B) . As observed in the case of Na ϩ -K ϩ -ATPase inhibition, Ϫ1 ⅐ h Ϫ1 (means Ϯ SE, n ϭ 12-11) for 14-and 19-day-old hepatocytes, respectively. Statistical significance was determined using one-way ANOVA and Newman-Keuls test for multiple comparison.
a P Ͻ 0.01 with respect to control. b P Ͻ 0.05 with respect to T3 and 3,5-T2.
c P Ͻ 0.05 with respect to cAMP.
19-day-old cells appeared significantly more responsive to hormone stimulation than their younger counterparts. Comparable results were obtained when IP 3 production was examined. In 14-day-old hepatocytes, IP 3 was increased about 50% of basal by T 3 and about 80% by 3,5-T 2 , whereas instead, in 19-day-old cells, the two hormones were equally effective in stimulating IP 3 production, with the increase being 75-100% of basal levels (Fig. 4) . Although it appears from the data reported in Fig. 4 that in the hepatocytes of both age groups, IP 3 and DAG were produced at similar rate, and most probably by PLC-mediated breakdown of PIP 2 , other mechanisms involving different and less specific phospholipases cannot be completely ruled out. -ATPase activity elicited by thyroid hormones; their effects were actually significantly enhanced by the MAPK inhibitor. The two inhibitors had no effects on Na ϩ -K ϩ -ATPase activity when present alone (Fig. 5, C and D) . A different result was obtained in younger cells (Fig. 5, A and B) , where wortmannin not only failed to block the inhibition of Na ϩ -K ϩ -ATPase activity induced by T 3 or 3,5-T 2 but actually produced a strong and significant inhibitory effect when present alone. Also, the response to the MAPK inhibitor was slightly changed in the 14-day-old cells. PD 98059 alone had no effect on Na ϩ -K ϩ -ATPase activity but significantly reinforced the inhibitory effect of T 3 and 3,5-T 2 when given in combination (Fig. 5, A and B) . These data suggest that activation of PI3-K plays a central role in the short-term inhibition of Na ϩ -K ϩ -ATPase activity by T 3 or 3,5-T 2 in 19-day old cells, whereas activation of the MAPK pathway seems to be independent of thyroid hormone mechanisms in both age groups.
Effect of T 3 and 3,5-T 2 on Na
DISCUSSION
We have previously shown that thyroid hormones inhibit, by a short-term mechanism, the Na ϩ -K ϩ -ATPase activity in a primary culture of chick embryo hepatocytes isolated at 14 and 19 days of embryonal age (37) . In the present study, we have investigated the signal transduction pathways involved in this hormonal effect, because this experimental system has been proved not only to respond to thyroid hormones by nongenomic mechanisms but also to reflect closely the in vivo situation, which is strongly related to the developmental age of the embryo.
Remarkable differences were found between 14-and 19-day-old cells with respect to both the basal levels of Na ϩ -K ϩ -ATPase activity and the response of the enzyme to the hormones. Our study demonstrated the following. 1) Chick embryo hepatocyte Na ϩ -K ϩ -ATPase shows a twofold increase in specific activity from 14-to 19-day development. 2) T 3 , T 3 -agarose, and 3,5-T 2 significantly inhibit Na ϩ -K ϩ -ATPase activity in both age groups after a treatment of only 5 min, which obviously indicates a nongenomic mechanism, well in line with current literature (17, 18, 35, 37) . 3) T 4 has no effect on chick embryo Na ϩ -K ϩ -ATPase activity. Because of the rapidity of the inhibitory response elicited by thyroid hormones, it is likely that the time available for deiodinase action does not allow for sufficient conversion of the prohormone T 4 into the efficient hormone T 3 . 4) As far as the effect on Na ϩ -K ϩ -ATPase activity is concerned, 3,5-T 2 behaves as a true thyroid hormone, as has already been shown for numerous physiolog- ical responses (2, 30, 31, 35, 37, 48, 51) , and is able to activate signal transduction pathways that lead to activation of protein kinases. 5) During embryonal development, the chick embryo Na ϩ -K ϩ -ATPase activity displays a varied flexibility to the modulatory action of the hormones and intracellular messenger systems. This has been explained by either differential expression of enzyme isoforms with distinct catalytic properties and characteristics at different developmental stages (22, 63) or the occurrence of age-related changes in membrane phospholipid composition and properties (26) such that membrane-associated transport activities are modified.
The rapid and transient inhibitory effect exerted by thyroid hormones on chick embryo hepatocyte Na 
/H
ϩ exchanger activity and system A amino acid transport in the same cells. The occurrence of the two opposite effects elicited by the hormones may be explained by considering their timing: Na ϩ -K ϩ -ATPase activity has already returned to basal level (15 min) when the activity of Na ϩ /H ϩ antiport and Na-dependent amino acid transport are maximally stimulated. The inhibition of the sodium pump and the subsequent activation of the Na ϩ /H ϩ exchanger result in an increase of intracellular Na ϩ content and cell volume that may be an early signal for a mitogenic response. A small increase of intracellular Na ϩ has been reported to be able to reverse the operation of the Na ϩ /Ca 2ϩ exchanger and transport Ca 2ϩ into the cell (4, 37, 56) . The consequent shift to higher intracellular Ca 2ϩ concentration inhibits the activity of the Na ϩ -K ϩ -ATPase, and more Na ϩ tends to accumulate into the cell. Eventually, Na ϩ accumulation results in an increase of intracellular water and cell swelling, a known anabolic signal in liver with respect to protein and carbohydrate metabolism and an activator of the MAPK pathway with consequent increase of phosphorylation of c-Jun and the corresponding mRNA level. Hyposmotic MAPK activation is of great physiological relevance for the regulation of cell function. In particular, changes in cell hydration trigger signal transduction cascades, which also are responsive to growth factors, cytokines, and different types of environmental stress that may be important for embryo survival and development (37) .
Numerous findings from in vitro and in vivo studies have amply documented that PKA-and PKC-dependent phosphorylation represents a pivotal event for the short-term modulation of Na ϩ -K ϩ -ATPase activity by different agents (22, 63) . It has been proposed that phosphorylation-induced conformational changes of the enzyme could modify the catalytic properties of the ␣-subunit or change the number of active enzyme units at the plasma membrane level through a complex mechanism, which requires translocation of the enzyme from/to the plasma membrane and activation of PI3-K and MAPK signaling pathways to regulate its trafficking between membrane and intracellular compartments (11-14, 23, 24) . Whatever the mechanism involved, it has been reported that phosphorylation of Na ϩ -K ϩ -ATPase ␣-subunit at specific serine residues, a very rapid event (2-5 min) (59), can produce stimulation, inhibition, or no direct effect on enzyme activity. The outcome appears to depend on the type of animal investigated, the tissue examined, the protein kinase isoforms involved, and the intracellular Ca 2ϩ concentration (22, 63) . Little information is available on the signal transduction pathways responsible for short-term modulation of this important activity by thyroid hormones. Nongenomic effects of T 3 on Na ϩ -K ϩ -ATPase have been reported by , who found that exposure of rat alveolar epithelial cells to the thyroid hormone over a wide concentration range (10 Ϫ9 -10 Ϫ5 M) resulted in a rapid and dose-dependent stimulation of Na ϩ -K ϩ -ATPase activity, which required the activation of Src kinases, PI3-K, and MAPK-ERK1/2 and was secondary to translocation of both ␣ 1 -and ␤ 1 -subunits of the enzyme to the plasma membrane. The authors hypothesized that activation of the MAPK-ERK1/2 pathway could represent the step necessary for the increase of Na ϩ -K ϩ -ATPase content on the plasma membrane. Neither PKA nor PKC seemed to be involved. The same authors recently reported T 3 stimulation of Na ϩ -K ϩ -ATPase activity in a primary culture of rat fetal epithelial cells isolated at 19 days of embryonal age (45) . As for the adult cells, the hormone effect was associated with an increase in the number of active enzyme molecules on the plasma membrane via a mechanism involving the activation of PI3-K. Hormone treatment of cells isolated at earlier developmental stages (17 and 18 days) was instead without any effect, suggesting that the ability to respond to thyroid hormone was an age-dependent characteristic acquired only in a later period of embryonal life. At variance with these results, our study demonstrates that in chick embryo hepatocytes, the ability to respond to thyroid hormones is already present at very early stages of development. The experiments show that not only activation of PKAand PKC-dependent mechanisms but possibly also PI3-Kmediated endocytosis take part in the inhibitory action of T 3 and 3,5-T 2 on Na ϩ -K ϩ -ATPase activity. At the same time, a role for MAPK-dependent mechanisms seems to be ruled out. Nongenomic effects of thyroid hormones involving activation of MAPK pathways have been reported in different cell types but require about 30 min to manifest (2, 5) . In the younger cells, RO 31-8220, calphostin C, and wortmannin were not only totally inefficient in preventing the inhibition by T 3 and 3,5-T 2 but also exerted a strong inhibitory effect of their own comparable to that elicited by the hormones (see Figs. 3 and 5) . The effects shown at this developmental stage, and at inhibitor concentrations normally employed to inhibit PKC or PI3-K activity in whole cells (1, 9, 55) , suggest a deep perturbation of cell machinery caused by an increased sensitivity of the younger cells to these inhibitors rather than a direct effect on pump functioning. From an inspection of data obtained in the presence of different agonists (dibutyryl-cAMP, PMA, or OAG) and the study of the second messengers produced (cAMP, DAG, and IP 3 ), we conclude that transduction pathways involving adenylate cyclase and PLC activities, leading to PKA, PKC, and, ultimately, PI3-K activation, are present and functioning already at the early stage of development.
At present, we cannot predict whether in our system the two protein kinases result in Na ϩ -K ϩ -ATPase inhibition through distinct and independent pathways or whether PKA-and PKCdependent phosphorylation of the ␣-subunit are synergistically related events such that to attain the full expression of hormone action, phosphorylation of PKC-dependent serine residues is potentiated by prior PKA action on its specific site, as proposed by others (7, 10) . In any case, the mechanism of Na ϩ -K ϩ -ATPase inhibition is likely to involve intracellular components, cytoskeletal elements, and, ultimately, endocytosis (11) (12) (13) (14) . A scheme of the possible events involved is reported in Fig. 6 . The observation that T 3 and the nonpermeant T 3 -agarose at the same concentration (100 nM) were equally efficient in inhibiting chick embryo hepatocyte Na ϩ -K ϩ -ATPase activity proves that T 3 interacts with a receptor at the plasma membrane. It is known that this nongenomic signal transduction pathway can activate intracellular second messenger systems (adenylate cyclase/cAMP, PLC/DAG) that result in PKA and PKC activation, as reported by several laboratories (5, 23, 34, 46) .
As mentioned in the Introduction, high-affinity binding sites for T 3 have been reported in several cell types, and in most cases the affinity was higher for T 3 than T 4 (3, 8, 28, 29, 32, 54) . Our data demonstrate that, in agreement with the higher affinity shown by the membrane receptors for 3,5-T 2 with respect to T 3 (31), 3,5-T 2 is able to mimic the effects of T 3 on the Na ϩ -K ϩ -ATPase activity even more efficiently than T 3 itself, as observed for other physiological responses, such as the stimulation of mitochondrial respiration (31) and the capability to activate signal transduction pathways that lead to protein kinase activation (2, 35, 37) . For the rapidity and potency of 3,5-T 2 , one can speculate that this metabolite might represent an alternative for the cells in critical situations, as already hypothesized for nonthyroidal illnesses (53) .
Cell proliferation is a pleiotropic event modulated by many factors, as shown by a number of articles on liver regeneration and development (2, 52) ; these include the extracellular matrix proteins (ECM) and cell-cell adhesion but also growth factors, cytokines, and hormones (57) . It has been reported that shortterm inhibition of the Na ϩ -K ϩ -ATPase can impair cell attachment to fibronectin, a process essential for cell development and differentiation, which appears to depend, at least partially, on intracellular Ca 2ϩ concentrations (4) . A previous article from some of us (2) has shown that during prenatal development, thyroid hormones T 4 , T 3 , and 3,5-T 2 are capable of modulating DNA synthesis and cell cycle proteins in chick embryo hepatocytes, probably through a nongenomic mechanism that requires activation of PKC␣ and the p42/44 MAPK pathway. The inhibition of chick embryo Na ϩ -K ϩ -ATPase by T 3 and 3,5-T 2 provides another example of nongenomic effects of thyroid hormones at different stages of development. By increasing intracellular Na ϩ and extracellular K ϩ levels, this also affects the intracellular Ca 2ϩ content, as previously shown for the same cells (37) and also for L-6 cells (16) . The increase in Ca 2ϩ is known to be related to integrin-mediated adhesion, cell attachment, and proliferation. In this context, T 3 and 3,5-T 2 appear to act directly as growth factors, since their effect on the sodium pump is more significant at the late stage of development.
